Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 6, 2005, Pages 1008-1012

  Ng, John ^a   Gosbell, Iain B ^a,b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Oral Antimicrobials; Staphylococcal infections; Streptogramins

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; FUSIDIC ACID; LINEZOLID; MACROLIDE; PRISTINAMYCIN; QUINOLONE DERIVATIVE; QUINUPRISTIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; AUSTRALIA; BACTERIAL ARTHRITIS; BONE INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PRESCRIPTION; PUBLIC HOSPITAL; RASH; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; OSTEOMYELITIS; PRISTINAMYCIN; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 21244441549     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki108     Document Type: Review

References (19)

1. Solomon, S. L., Horan, T., Andrus, M. et al. (2003). National nosocomial infections surveillance (NNIS) system report: data summary from January 1992 through June 2003. Am J Infect Control 31, 481-98.
2. Nimmo, G. R., Bell, J. M., Mitchell, D. et al. (2003). Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals. Microb Drug Resist 9, 155-60.
3. Cocito, C. (1979). Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev 43, 145-98.
4. Paris, J. M., Barriere, J. C., Smith, C., et al. (1990). The chemistry of pristinamycins. In Recent Progress in the Chemical Synthesis of Antibiotics, pp. 185-245. Springer-Verlag, Berlin.
5. Mutton, K. J. & Andrew, J. H. (1983). In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus. Chemotherapy 29, 218-24.
6. Lefevre, J. C. & Bauriaud, R. (1989). Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens. Antimicrob Agents Chemother 33, 2152-4.
7. Fass, R. J. (1991). In vitro activity of RP 59500, a semisynthetic injectable pristinamycin against staphylococci, streptococci and enterococci. Antimicrob Agents Chemother 35, 553-9.
8. Brumfitt, W., Hamilton-Miller, J. M. T. & Shah, S. (1992). In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic against Gram positive bacteria. J Antimicrob Chemother 30, Suppl A, 29-37.
9. Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards (2005). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI/NCCLS Document M100-S15. NCCLS, Villanova, PA, USA.
10. Leclercq, R., Nanatas, L., Soussy, C. J. et al. (1992). Activity of RP 59500, a new parenteral semi-synthetic streptogramin against staphylococci with various mechanisms of resistance to macrolidelincosamide-streptogramin antibiotics. J Antimicrob Chemother 30, Suppl A, 67-75.
11. Fantin, B., Leclercq, R., Merle, Y. et al. (1995). Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob Agents Chemother 39, 400-5.
12. Schmitz, F. J., Verhoef, J. & Flint, A. C. (1999). Prevalence of resistance to MLS antibiotics in 20 European university teaching hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother 43, 783-92.
13. Werner, G., Cuny, C., Schmitz, F. J. et al. (2001). Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J Clin Microbiol 39, 3586-90.
14. Quentin, C., Grobost, F., Fisher, I. et al. (2001). Antibiotic resistance of Staphylococcus aureus in urban experience: 6 month study in Aquitaine. Pathol Biol 49, 33-40.
15. Leclercq, R., Soussy, C. J., Weber, P. et al. (2003). In vitro activity of pristinamycin against isolated staphylococci in French hospitals in 1999-2000. Pathol Biol 51, 400-4.
16. Maple, P. A., Hamilton-Miller, J. M. & Brumfitt, W. (1989). World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet, i8637, 537-40.
17. Dancer, S. J., Robb, A., Crawford, A. et al. (2003). Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. J Antimicrob Chemother 51, 731-5.
18. Bernard, P., Risse, L. & Bonnetblanc, J. M. (1996). [Pristinamycin in the treatment of acute bacterial dermohypodermatitis in adults: an open study of 42 patients]. Ann Dermatol Venereol 123, 16-20.
19. Wilcox, M. H. (2003). Efficacy of linezolid versus comparator therapies in Gram positive infections. J Antimicrob Chemother 51, Suppl 2, ii27- ii35.